apollo
logo
0Login
Introducing Our Latest Arrival!
Lumigo-120 Injection 1's

Lumigo-120 Injection 1's

Prescription drug
 Trailing icon
Consult Doctor

Composition

ARTESUNATE-120MG

Manufacturer/Marketer

Brochem Health Care Pvt Ltd

Consume Type

PARENTERAL

Return Policy

Not Returnable

Expires on or after

Jan-26

for this medicine

About Lumigo-120 Injection

Lumigo-120 Injection belongs to the class of 'anti-malarial drugs', primarily used to treat malaria. Malaria is a disease caused by a plasmodium parasite, transmitted by the bite of infected Anopheles mosquitoes. When an infected mosquito bites a healthy person, it transmits the 'Plasmodium parasite' into the bloodstream, which affects the red blood cells and liver cells. Malaria symptoms usually start 10 days to 4 weeks after the infection. They include chills, high fever, profuse sweating, headache, nausea, vomiting, abdominal pain, diarrhea, anemia, muscle pain, convulsions, coma, and bloody stools.

Lumigo-120 Injection contains ‘Artesunate’. This Lumigo-120 Injection is antimalarial medicine that interferes with the plasmodium parasite's growth in the red blood cells of the human body. Lumigo-120 Injection is used to treat malaria caused by a parasite called 'Plasmodium falciparum,' another plasmodium species.  It works by forming harmful chemicals within the malarial parasite, therefore killing the parasites.

Lumigo-120 Injection will be administered by a healthcare professional; do not self-administer. You may experience dizziness, headache, weakness, and loss of appetite (not feeling hungry). Most of these side effects of Lumigo-120 Injection do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.

Before using Lumigo-120 Injection, inform your doctor if you recently used any prescription and non-prescription medications, including other anti-malarial or antibiotic drugs. Let your doctor know if you are allergic to Lumigo-120 Injection or its components. Inform your doctor if you have any liver or kidney problems. It is essential to let your doctor know if you are pregnant, planning to conceive, or are a breastfeeding mother. Lumigo-120 Injection causes drowsiness and dizziness it is advisable to avoid driving unless you are alert.

Uses of Lumigo-120 Injection

Treatment of Malaria

Medicinal Benefits

Lumigo-120 Injection contains ‘Artesunate’. This Lumigo-120 Injection is antimalarial medicine that interferes with the plasmodium parasite's growth in the red blood cells of the human body. It is used to treat cerebral malaria and all kind of severe malaria. The antimalarial effect of Lumigo-120 Injection is commonly identified as generally safe, highly efficient and well-tolerated. Lumigo-120 Injection is used to treat malaria caused by a parasite called 'Plasmodium falciparum,' other plasmodium species.  It works by forming harmful chemicals within the malarial parasite, therefore killing the parasites.

Directions for Use

Lumigo-120 Injection will be administered by a healthcare professional; do not self-administer.

Storage

Store in a cool and dry place away from sunlight

Side Effects of Lumigo-120 Injection

  • Dizziness
  • Headache
  • Weakness
  • Loss of appetite (not feeling hungry)

 

Drug Warnings

Inform your doctor if you have any allergic reactions to Lumigo-120 Injection or its components. Brief your medical history to the doctor if you have any liver or kidney problems, or heart disease. Blood problems may occur after you receive treatment with this Lumigo-120 Injection. Inform your doctor immediately if you or your child have pain in the leg, back, or stomach, chills, bleeding gums, difficulty breathing, dark urine, general body swelling, fever, loss of appetite (feeling not hungry), headache, nosebleeds, nausea, or vomiting, sore throat, pale skin, unusual tiredness or weakness, or yellow skin or eyes. Inform your doctor immediately if you or your child have chest tightness, blurred vision, cough, confusion, faintness, dizziness, or lightheadedness. When getting up unexpectedly from a sitting or lying position, skin rash, redness of the skin, itching, sweating, swelling of your face, hands, or mouth, trouble breathing or swallowing, or unusual weakness or tiredness after you receive this Lumigo-120 Injection. It is essential to let your doctor know if you are pregnant, planning to conceive, or are a breastfeeding mother. Lumigo-120 Injection causes drowsiness and dizziness it is advisable to avoid driving unless you are alert.

Drug Interactions

Drug-Drug Interactions: Lumigo-120 Injection may interact with other anti-malarial drugs (mefloquine), medicines for HIV (pyrimethamine).

Drug-Food Interactions: No interactions found.

Drug-Disease Interactions: Before using Lumigo-120 Injection, let your doctor know if you have an allergy, heart disease, kidney disease, and liver disease.

Drug-Drug Interactions Checker List

  • MEFLOQUINE
  • PYRIMETHAMINE

Habit Forming

No

Diet & Lifestyle Advise

  • Take nutritious food, including fresh fruits and vegetables that help in recovering from malarial fever.
  • During malarial fever, the patient may experience appetite loss. In such cases, drink glucose water, fresh fruit juices, and coconut water.
  • Include high-fiber foods like green leafy vegetables and fruits to aid digestion.
  • Take proper rest to help your body relax and heal faster.
  • Avoid or limit the intake of alcohol and caffeine.

Special Advise

 

Disease/Condition Glossary

Malaria: It is a life-threatening disease caused by parasites that enter the body through a mosquito's bite. This is a common disease in countries like Africa, South America, and Southern Asia. This disease usually occurs when an Anopheles mosquito (infected with the parasite 'Plasmodium') bites a healthy individual and transfers the parasite into the bloodstream. Parasites that cause malaria include Plasmodium vivax, P. ovale, P. malaria, and P. falciparum. Malaria symptoms usually start 10 days to 4 weeks after the infection. They include chills, high fever, profuse sweating, headache, nausea, vomiting, abdominal pain, diarrhea, anemia, muscle pain, convulsions, coma and bloody stools.

bannner image

Alcohol

Caution

Avoid alcohol while using Lumigo-120 Injection since it can worsen your side effects.

bannner image

Pregnancy

Unsafe

Lumigo-120 Injection is not safe during pregnancy as it causes severe side effects to both mother and unborn baby.

bannner image

Breast Feeding

Caution

Lumigo-120 Injection is present in breast milk but may not be expected to cause any side effects in the new-born baby especially more than 2 months. Please use only in the condition if your doctor is prescribed.

bannner image

Driving

Caution

Lumigo-120 Injection may make you feel sleepy, dizzy, or generally weak. In such cases, do not drive or operate machinery.

bannner image

Liver

Caution

Close monitoring of patients with liver diseases while being treated with Lumigo-120 Injection is required. Let your doctor know if you have any history of liver diseases before using Lumigo-120 Injection. No specific dose adjustments are needed.

bannner image

Kidney

Caution

Therapy with Lumigo-120 Injection is to be cautiously administered in patients with renal impairment. Let your doctor know if you have any history of kidney diseases before using Lumigo-120 Injection. No specific dose adjustments are needed.

bannner image

Children

Safe if prescribed

Lumigo-120 Injection is safely given to the children 6 months or older.

Country of origin

India

Manufacturer/Marketer address

Sector-18, Vashi, Navi Mumbai Maharashtra (India) Pin-400705
Other Info - LUM0283

FAQs

Lumigo-120 Injection is used to treat malaria.
Lumigo-120 Injection is antimalarial medicine that interferes with the plasmodium parasite's growth in the red blood cells of the human body. Lumigo-120 Injection is used to treat malaria caused by a parasite called "Plasmodium falciparum," other plasmodium species. It works by forming harmful chemicals within the malarial parasite, therefore killing the parasites.
Use of Lumigo-120 Injection should be prevented in patients who are allergic to Lumigo-120 Injection or any of its components. Though, if you are not aware of any allergy or if you are using Lumigo-120 Injection for the first time, inform your doctor.
Before starting Lumigo-120 Injection, inform your doctor if you have any other health illnesses like a kidney- or heart-related complications. This is because some medical conditions may affect your treatment and you may even require dose adjustments. Also, inform your doctor about all the other medicines you are taking as they may affect, or be affected by, this Lumigo-120 Injection. Talk to your doctor if you are pregnant, planning to become pregnant or breastfeeding.
If you miss a dose of Lumigo-120 Injection, take it as soon as you remember. Although, if it is approximately time for your next dose, skip the missed dose and take the next dose in the recommended time. Do not double the dose to make up for the missed one as this may enhance the probabilities of developing side effects.
Store Lumigo-120 Injection between 10°C to 30°C according to the instructions on the leaflet and away from direct sunlight.
No, finish the prescribed course, even if you start to feel better. Stopping it early may make the infection come back and harder to treat.

Disclaimer

While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.